SCHEMBL7753044

SCHEMBL7753044

NC(=O)CC(Sc1ccccn1)N1C(=O)CCC1=O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
ALDH1A1 P00352 6/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 2/20 0.37
EHMT2 Q96KQ7 1/20 0.34
EHMT1 Q9H9B1 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL616909 0.90 ALDH1A1 (0.43) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL5162362 0.82 HPGD (0.38) SMN1; SMN2HSD17B10HPGDALDH1A1KMT2A
SCHEMBL2002799 0.80 ALDH1A1 (0.46) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL6687766 0.77 ALDH1A1 (0.42) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL8082242 0.76 EHMT2 (0.38) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL28279888 0.73 ALDH1A1 (0.40) POLBSMN1; SMN2HSD17B10ALDH1A1KMT2A
SCHEMBL177980 0.73 ALDH1A1 (0.48) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL10980060 0.72 KMT2A (0.38) SMN1; SMN2HPGDALDH1A1KMT2AMAPT
SCHEMBL616908 0.72 ALDH1A1 (0.54) POLBSMN1; SMN2HSD17B10HPGDALDH1A1
SCHEMBL9359541 0.72 LMNA (0.41) POLBSMN1; SMN2HSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001045669-A1 THERAPEUTIC USE OF PARTICLES DISPLAYING PATHOGEN-SPECIFIC BINDING MOIETIES ELUSYS THERAPEUTICS, INC. (US) 2001-06-28 WO disclosed